Chloe E Atreya

Chloe E Atreya

UNVERIFIED PROFILE

Are you Chloe E Atreya?   Register this Author

Register author
Chloe E Atreya

Chloe E Atreya

Publications by authors named "Chloe E Atreya"

Are you Chloe E Atreya?   Register this Author

27Publications

2431Reads

32Profile Views

Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers.

PLoS One 2018 23;13(7):e0199423. Epub 2018 Jul 23.

Department of Medicine and Helen Diller Family Comprehensive Cancer Center (HFCCC), University of California, San Francisco (UCSF), San Francisco, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199423PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056029PMC
January 2019

Applying New Models of Care to Meet Patient Needs in Integrative Oncology.

J Altern Complement Med 2018 Sep/Oct;24(9-10):1010-1011

1 UCSF Osher Center for Integrative Medicine , San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/acm.2018.0151DOI Listing
December 2018

Of Microbes and Microsatellites.

Cancer Immunol Res 2018 11;6(11):1290-1291

Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-18-0567DOI Listing
November 2018

Emerging treatment options for -mutant colorectal cancer.

Gastrointest Cancer 2018 22;8:13-23. Epub 2018 Mar 22.

Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/GICTT.S125940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889076PMC
March 2018

Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.

Am Soc Clin Oncol Educ Book 2017 ;37:246-256

From the Gastrointestinal Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Memorial Sloan Kettering Cancer Center, New York, NY; University of Pittsburgh Cancer Institute, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175679DOI Listing
December 2017

Sampling strategies to capture single-cell heterogeneity.

Nat Methods 2017 Oct 4;14(10):967-970. Epub 2017 Sep 4.

Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nmeth.4427
Publisher Site
http://dx.doi.org/10.1038/nmeth.4427DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658002PMC
October 2017

Role of Biologics in Colon Cancer: Still Not Clear.

J Oncol Pract 2016 12;12(12):1229-1230

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.018697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455590PMC
December 2016

Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.

J Natl Compr Canc Netw 2016 12;14(12):1536-1543

From the Department of Medicine and Helen Diller Family Comprehensive Cancer Center; Department of Radiology and Biomedical Imaging; and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551390PMC
http://dx.doi.org/10.6004/jnccn.2016.0165DOI Listing
December 2016

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.

J Clin Oncol 2015 Dec 21;33(34):4023-31. Epub 2015 Sep 21.

Ryan B. Corcoran, Eunice L. Kwak, and David P. Ryan, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; Chloe E. Atreya, Adil Daud, and Alan P. Venook, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles, CA; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver; Wells A. Messersmith, University of Colorado Cancer Center and University of Colorado, Aurora, CO; Johanna C. Bendell, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Razelle Kurzrock and Scott Kopetz, University of Texas, MD Anderson Cancer Center, Houston, TX; Mariaelena Pierobon, Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA; Peng Sun, Elizabeth Cunningham, Shonda Little, Keith Orford, Monica Motwani, and Yuchen Bai, GlaxoSmithKline, Philadelphia, PA; and Kiran Patel, Incyte, Wilmington, DE.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/34/4023.full.pdf
Web Search
http://jco.ascopubs.org/content/suppl/2015/09/21/JCO.2015.63
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.2471
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.2471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669588PMC
December 2015

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

Cancer Discov 2015 Oct 24;5(10):1040-8. Epub 2015 Jun 24.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. Department of Medicine, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592417PMC
October 2015

Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.

Int J Cancer 2015 Apr 29;136(8):1967-75. Epub 2014 Sep 29.

Division of Medical Oncology, University of Colorado Denver and University of Colorado Cancer Center, Aurora, CO; Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323738PMC
April 2015

Expanded RAS: refining the patient population.

J Clin Oncol 2015 Mar 12;33(7):682-5. Epub 2015 Jan 12.

The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.9325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334773PMC
March 2015

Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Clin Cancer Res 2013 Oct 27;19(20):5777-87. Epub 2013 Aug 27.

Authors' Affiliations: Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina; Dana-Farber Cancer Institute; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts; The Ohio State University, Columbus, Ohio; National Cancer Institute, Bethesda, Maryland; and Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122229PMC
October 2013

PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival.

Cancer Med 2013 Aug 10;2(4):496-506. Epub 2013 Jun 10.

Department of Internal Medicine Division of Hematology/Oncology Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799284PMC
August 2013

Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer.

Invest New Drugs 2012 Dec 24;30(6):2219-25. Epub 2012 Jan 24.

Division of Hematology/Oncology, UCSF Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10637-012-9793
Web Search
http://link.springer.com/10.1007/s10637-012-9793-y
Publisher Site
http://dx.doi.org/10.1007/s10637-012-9793-yDOI Listing
December 2012

Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis.

Biochemistry 2007 Jul 20;46(28):8379-91. Epub 2007 Jun 20.

Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi700531rDOI Listing
July 2007

Kinetic characterization of bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) from Cryptosporidium hominis: a paradigm shift for ts activity and channeling behavior.

J Biol Chem 2004 Apr 12;279(18):18314-22. Epub 2004 Feb 12.

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M400009200DOI Listing
April 2004

Probing electrostatic channeling in protozoal bifunctional thymidylate synthase-dihydrofolate reductase using site-directed mutagenesis.

J Biol Chem 2003 Aug 17;278(31):28901-11. Epub 2003 May 17.

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M212689200DOI Listing
August 2003

Mechanistic characterization of Toxoplasma gondii thymidylate synthase (TS-DHFR)-dihydrofolate reductase. Evidence for a TS intermediate and TS half-sites reactivity.

J Biol Chem 2002 Nov 20;277(45):43126-36. Epub 2002 Aug 20.

Department of Pharmacology, School of Medicine, Yale University, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M206523200DOI Listing
November 2002